Abstract: A display device includes a display panel including a flexible region and a low flexibility region, wherein the flexible region may include a first transistor including a first semiconductor layer and a first gate electrode, a first conductor connected to the first semiconductor layer, and a first interlayer insulating layer between the first transistor and the first conductor. The low flexibility region may include a second transistor including a second semiconductor layer and a second gate electrode, a second conductor connected to the second semiconductor layer, and a second interlayer insulating layer between the second transistor and the second conductor. The first interlayer insulating layer may include an organic insulating material, the second interlayer insulating layer includes an inorganic insulating material, and a ratio of channel width to channel length of the first transistor may be different from that of the second transistor.

Abstract: The present invention relates to a novel phenylsulfonyl oxazole derivative and a use thereof and specifically, to a compound represented by Chemical Formula 1 in the present specification or a pharmaceutically acceptable salt thereof, and to a use thereof for prevention, treatment, or improvement of neurodegenerative disease.

Abstract: The present invention relates to a composition for diagnosis of degenerative neurological diseases and, more specifically, to a composition for diagnosis of degenerative neurological diseases, comprising an agent for measuring the level of acetylation of COX2. According to the present invention, since acetylation of COX2 in degenerative neurological diseases is significantly reduced, whether COX2 is acetylated may be utilized as a diagnostic marker for degenerative neurological diseases, and it is possible to diagnose degenerative neurological diseases more rapidly and accurately by using same.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating neurodegenerative diseases comprising a COX2 acetylating agent as an active ingredient and, more particularly, to a pharmaceutical composition for preventing or treating neurodegenerative diseases comprising, as an active ingredient, a COX2 acetylating agent which exhibits an effect of inhibiting the deposition of amyloid-? in brain neurons, reducing excessive neuroinflammatory responses, and increasing the phagocytosis of amyloid-? in microglial cells. The pharmaceutical composition for preventing or treating neurodegenerative diseases comprising the COX2 acetylating agent as an active ingredient has the effects of alleviating neuroinflammation by promoting COX2 acetylation in neurons and secreting specialized pro-resolving mediators (SPMs) and thus, can be very useful in the development of a preventive or therapeutic agent for neurodegenerative diseases.

Abstract: A pixel and a display device including the same are disclosed. In one aspect, the pixel includes an organic light-emitting diode (OLED) and a reflection layer facing the OLED and configured to reflect light emitted from the OLED. The pixel also includes a photosensor configured to measure luminance of the reflected light. The photosensor is placed on a rear side of the OLED.

Abstract: A home appliance is provided. The home appliance includes at least one light emitting diode (LED) for individually displaying each of selected states of at least one function provided by the home appliance, and a processor for controlling, based on a user voice being inputted, the at least one LED so as to indicate that the inputted voice is being recognized, and based on the voice recognition being completed, controlling the at least one LED so as to allow the at least one LED to be turned on according to the voice recognition.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating neurodegenerative disease, containing, as active ingredients, cyclodextrin and stem cells in which VEGF is overexpressed. A combined treatment of cyclodextrin and stem cells in which VEGF is overexpressed has remarkable synergistic effects, with respect to therapeutic efficacy on the disease, such as a lifespan increase, mobility improvement, inhibition of neurogenic inflammation, inhibition of nerve cell apoptosis and inhibition of lipid accumulation in organs, including the brain, on a neurodegenerative disease model, thereby presenting a novel therapeutic strategy.

Abstract: The present disclosure in some embodiments provides a method of generating an object-inserted image. A method in some embodiments is performed by an electronic device for inserting one or more objects into a main image to generate an object-inserted image, including determining a first position for inserting a second object into the main image in response to a user input, and identifying whether a first object is absent or present as a preinserted object at the first position in the main image, and inserting the second object at the first position in the main image when the first object is absent, and inserting the second object at a second position in the first object based on a user selection when the first object is present.

Abstract: Image panning method is disclosed. Embodiments provide a method performed by a device for placing a second object on a first object on screen, including moving the first object on screen, responsive to a drag moving the second object over first object in first direction, in a second direction opposite to first direction, and placing the second object at end position of the drag in the first object, when the drag is terminated for the second object, wherein the moving of first object in second direction includes moving, even when the end of the first object reaches an end of the screen, the first object continuously in the second direction in accordance with the drag of the second object in the first direction, to thereby allow a drag for moving the second object to a vicinity of an end of the first object or to an outside area of the first object beyond the end of the first object.

Abstract: Disclosed herein is a method of creating an image stitching workflow including acquiring 360-degree virtual reality (VR) image parameters necessary to makes a request for image stitching and create the image stitching workflow, acquiring a list of functions applicable to the image stitching workflow, creating the image stitching workflow based on functions selected from the list of functions, determining the number of media processing entities necessary to perform tasks configuring the image stitching workflow and generating a plurality of media processing entities according to the determined number of media processing entities, and allocating the tasks configuring the image stitching workflow to the plurality of media processing entities.

Abstract: A reverse osmosis filtering module includes: a purified water discharge pipe in which a purified water discharge path is formed, and which has a communication hole that is formed on an outer periphery thereof and communicates with the purified water discharge path; a reverse osmosis filtering part including a reverse osmosis filtering member in which a purified water flow space is formed, and which is wound around the purified water discharge pipe such that the purified water flow space communicates with the communication hole; a first flow channel formation cap provided at one side and having an inlet hole; and a second flow channel formation cap provided at the other side of the reverse osmosis filtering part and having an outlet hole.

Abstract: The present invention relates to a nucleic acid complex having a novel structure, which can introduce a bioactive nucleic acid into cells, a composition for treating and diagnosing disease, which comprises the same, and a method of regulating expression of a target gene using the same, and more particularly to a nucleic acid complex comprising a bioactive nucleic acid complementarily bound to a carrier peptide nucleic acid modified to be generally positively charged, a composition for treating and diagnosing disease, which comprises the same, and a method of regulating expression of a target gene using the same.

Abstract: The present invention relates to a method for treating degenerative neurological disorders in a subject in need thereof, comprising administering to a subject in need thereof a therapeutically effective amount of a composition comprising an acid sphingomyelinase (ASM) activity inhibitor or expression inhibitor as an active ingredient.

Abstract: Provided is a method for diagnosing a state of reusable (SOR) of a battery and, more specifically, to a method for diagnosing an SOR of a battery, the method being capable of diagnosing the overall state of a battery during battery reuse by separately diagnosing a state of health (SOH) and a state of power (SOP) of the battery. The method for diagnosing a state of reusable (SOR) of a battery according to the present invention includes: estimating a state of charge (SOC) according to a change in an open circuit voltage (OCV); estimating a state of health (SOH) by using the SOC; calculating a state of power (SOP) in consideration of an output of a current battery; and calculating the SOR by using the SOH and the SOP.

Abstract: Disclosed are a method for analyzing a melting curve using bi-functional fluorescent PNA probes, a method for diagnosing microsatellite instability (MSI) using the same, and a kit for diagnosing microsatellite instability (MSI) using the same. More particularly, disclosed are a method for analyzing a melting curve, based on the structure of fluorescent PNA probes that bind with different binding forces depending on the number of base mutations deleted using the fluorescent PNA probes capable of specifically binding to regions where the same base is repeated, and a method for rapidly and accurately detecting and analyzing microsatellite instability (MSI) by detecting gene mutation of microsatellite markers caused by base deletion in regions where the same base is repeated using the analysis method and analyzing the number of base mutations thus obtained.

Abstract: An organic light-emitting diode display device includes a first substrate that includes a display region with a plurality of pixels and a non-display region in a periphery of the display region, a first electrode disposed on the first substrate, a second electrode opposed to the first electrode, an organic light-emitting layer disposed between the first electrode and the second electrode, and at least one light sensing member disposed on a rear surface of the first substrate that overlaps the display region.

Abstract: There is provided an image processing apparatus and method. The image processing apparatus comprises: receiving a first source image and a second source image from multiple image sources, receiving geometric information required for stitching the first source image and the second source image and synthesizing an image from the first source image and the second source image on the basis of the geometric information, wherein the geometric information includes seam information used to specify a overlapping region between the first source image and the second source image.

Abstract: The present disclosure relates to a method for producing a TLR5 agonist protein. According to the present disclosure, the TLR5 agonist protein can be easily separated and purified after biotechnological production. In particular, the fusion partner used for separation and purification is effectively removed so as to minimize the possibility of inhibiting binding to TLR5 and inducing an immune response by the fusion partner.

Abstract: The present invention relates to a method for treating degenerative neurological disorders in a subject in need thereof, comprising administering to a subject in need thereof a therapeutically effective amount of a composition comprising an acid sphingomyelinase (ASM) activity inhibitor or expression inhibitor as an active ingredient.

Abstract: The present invention relates to a novel peptide exhibiting an effect of releasing myelopoiesis stem cells into blood and an osteoporosis therapeutic effect and use thereof and, in particularly, to a novel peptide consisting of an amino acid sequence of SEQ. ID.NO:1 which has effects of releasing hematopoietic stem cells into a bloodstream and decreasing osteoclast cells in bone narrow, and a pharmaceutical composition comprising the novel peptide as an active ingredient for preventing or treating neutropenia, anemia or osteoporosis. Because of side effects, the peptide of the present invention not only increases level of leukocytes, red blood cells and platelets in blood, but also alleviates a decrease in bone density, and therefore, can be very usefully used for the development of a prophylactic or therapeutic agent for neutropenia, anemia or osteoporosis.